(Source: State Street Corporation) BOSTON--(BUSINESS WIRE)--The SPDR® Exchange Traded Fund (ETF) listed in the table below, announced today that the Fund received a payment as an authorized claimant from a class action settlement related to Hospira, Inc. (NYSE: HSP). The total payment to be received by the Fund is listed below. When the Fund calculates its net asset value ("NAV") per share on Friday, September 25, 2015, it is estimated that the Fund's NAV will be impacted in the amount stated below based on shares outstanding as of September 23, 2015. Fund Payment Amount Shares Outstanding as of September 23, 2015 Per Share Impact SPDR® S&P Pharmaceuticals ETF (XPH) $126,658...
↧